"what happened here" is not a typical CP insider vent/ rant....are you working on a CI report? tsamadda, no one will knowingly speak with you
This company is like an accordion. Expanding just to contract. There isn't enough business to divide HIV and HCV. Company will find this out soon and go back to having them with the same sales force. This will lead to cuts once again!
Baraclude, Sustiva and Atripla all going off patent early next year so everyone is scrambling to get off working on these brands as fast as possible so they don't end up with the same fate as those who were on Abilify by year end. Reyataz isn't going to be enough to keep the franchise unit fully staffed.